The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Open accessAbstract
Growth of numerous cancer types is believed to be driven by a subpopulation of poorly differentiated cells, often referred to as cancer stem cells (CSCs), that have the capacity for self-renewal, tumor initiation, and generation of nontumorigenic progeny. Despite their potentially key role in tumor establishment and maintenance, the energy requirements of these cells and the mechanisms that regulate their energy production are unknown. Here, we show that the oncofetal insulin-like growth factor 2 mRNA-binding protein 2 (IMP2, IGF2BP2) regulates oxidative phosphorylation (OXPHOS) in primary glioblastoma (GBM) sphere cultures (gliomaspheres), an established in vitro model for CSC expansion. We demonstrate that IMP2 binds several mRNAs that encode mitochondrial respiratory chain complex subunits and that it interacts with complex I (NADH:ubiquinone oxidoreductase) proteins. Depletion of IMP2 in gliomaspheres decreases their oxygen consumption rate and both complex I and complex IV activity that results in impaired clonogenicity in vitro and tumorigenicity in vivo. Importantly, inhibition of OXPHOS but not of glycolysis abolishes GBM cell clonogenicity. Our observations suggest that gliomaspheres depend on OXPHOS for their energy production and survival and that IMP2 expression provides a key mechanism to ensure OXPHOS maintenance by delivering respiratory chain subunit-encoding mRNAs to mitochondria and contributing to complex I and complex IV assembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Marker-independent identification of glioma-initiating cells
Clément, V., Marino, D., Cudalbu, C., Hamou, M., Mlynárik, V., de Tribolet, N., Dietrich, P., Rolf Gruetter, A., Hegi, M. E., & Radovanovic, I. (2010) · Nature Methods · doi:10.1038/nmeth.1430 · Cited by 81
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · cited 3×
“For Kaplan-Meier survival analysis, only patients that had received both chemotherapy and radiation therapy were considered, and proneural samples were selected based on assignment from Verhaak et al. (2010).”
BackgroundMethodInfluentialIdentification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783 · cited 2×
“…receptors CD34 and CD38 have helped define leukemia stem cells based on their convincing validation as markers of normal hematopoietic stem cells (Lapidot et al. 1994), the developmental hierarchy of most tissues that develop solid tumors is insufficiently char8These authors contributed equally…”
BackgroundIdentification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 1×
“…was, in fact, established by the demonstration that Imp2 is a target of mTOR (Dai et al. 2011), a kinase complex that is tightly coupled to cellular bioenergetics (for review, see Zoncu et al. 2011). mTOR was shown to phosphorylate Imp2, which results in its increased binding to IGF2 mRNA.”
BackgroundTumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668 · cited 1×
“Resistance to therapy is often attributed to CSCs but does not constitute a defining trait (Dean et al. 2005).”
Background(1989) · PubMed · Cited by 3,343
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., & Mesirov, J. P. (2006) · Nature Genetics · doi:10.1038/ng0506-500 · Cited by 2,032
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354 · cited 6×
“Both locations have been shown to be enriched in CSCs (Li et al. 2009; Anido et al. 2010; Charles et al. 2010).”
BackgroundInfluentialGlioblastoma stem-like cells give rise to tumour endothelium
Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K. E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., & Tabar, V. (2010) · Nature · doi:10.1038/nature09624 · Cited by 1,203
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,050
Self-citationNeuronal and glioma-derived stem cell factor induces angiogenesis within the brain
Sun, L., Hui, A.-M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Menon, J., Walling, J., Bailey, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.003 · Cited by 877
Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A. H., Wewer, U. M., & Nielsen, F. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1262 · Cited by 721
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Son, M. J., Woolard, K., Nam, D.-H., Lee, J., & Fine, H. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.003 · Cited by 672
MOLECULAR PATHOLOGY OF MALIGNANT GLIOMAS
Louis, D. N. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100043 · Cited by 648
The therapeutic promise of the cancer stem cell concept
Frank, N. Y., Schatton, T., & Frank, M. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41004 · Cited by 636
IMPORT OF PROTEINS INTO MITOCHONDRIA
Glick, B., & Schatz, G. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000321 · Cited by 578
Anido, J., Sáez-Borderías, A., Gonzàlez-Juncà, A., Rodón, L., Folch, G., Carmona, M. A., Prieto-Sánchez, R. M., Barba, I., Martínez-Sáez, E., Prudkin, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.023 · Cited by 572
Rong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Metabolic state of glioma stem cells and nontumorigenic cells
Vlashi, E., Lagadec, C., Vergnes, L., Matsutani, T., Masui, K., Poulou, M., Popescu, R., Della Donna, L., Evers, P., Dekmezian, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106704108 · Cited by 553
Charles, N., Ozawa, T., Squatrito, M., Bleau, A.-M., Brennan, C. W., Hambardzumyan, D., & Holland, E. C. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.01.001 · Cited by 550
Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma?
Jose, C., Bellance, N., & Rossignol, R. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.012 · Cited by 518
Bovine Complex I Is a Complex of 45 Different Subunits
Carroll, J., Fearnley, I. M., Skehel, J. M., Shannon, R. J., Hirst, J., & Walker, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607135200 · Cited by 487
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Suvà, M.-L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J.-C., Baumer, K., Le Bitoux, M.-A., Marino, D., Cironi, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1622 · Cited by 465
Self-citationBlue Native electrophoresis to study mitochondrial and other protein complexes
Nijtmans, L. (2002) · Methods · doi:10.1016/s1046-2023(02)00038-5 · Cited by 366
Analysis of the Subunit Composition of Complex I from Bovine Heart Mitochondria*S
Carroll, J., Fearnley, I. M., Shannon, R. J., Hirst, J., & Walker, J. E. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300014-mcp200 · Cited by 364
Wakimoto, H., Kesari, S., Farrell, C. J., Curry, W. T., Zaupa, C., Aghi, M., Kuroda, T., Stemmer-Rachamimov, A., Shah, K., Liu, T.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3886 · Cited by 361
Mitochondrial import and the twin-pore translocase
Rehling, P., Brandner, K., & Pfanner, N. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1426 · Cited by 355
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Joo, K. M., Kim, S. Y., Jin, X., Song, S. Y., Kong, D.-S., Lee, J.-I., Jeon, J. W., Kim, M. H., Kang, B. G., Jung, Y., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.57 · Cited by 337
Lottaz, C., Beier, D., Meyer, K., Kumar, P., Hermann, A., Schwarz, J., Junker, M., Oefner, P. J., Bogdahn, U., Wischhusen, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1707 · Cited by 272
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Wakimoto, H., Mohapatra, G., Kanai, R., Curry, W. T., Yip, S., Nitta, M., Patel, A. P., Barnard, Z. R., Stemmer-Rachamimov, A. O., Louis, D. N., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor195 · Cited by 244
Mason, M. G., Nicholls, P., Wilson, M. T., & Cooper, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506562103 · Cited by 233
Fernández-Vizarra, E., Tiranti, V., & Zeviani, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.028 · Cited by 214
mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry
Dai, N., Rapley, J., Angel, M., Yanik, M. F., Blower, M. D., & Avruch, J. (2011) · Genes & Development · doi:10.1101/gad.2042311 · Cited by 208 · cited 4×
“In human tissues, low levels of Imp2 transcripts have been detected in adult bone marrow, colon, kidney, salivary glands, small intestine, and gonads (Hammer et al. 2005), whereas its protein has thus far been reported only in the islets of Langerhans (Dai et al. 2011) and gonads (Hammer et al. 2005).”
BackgroundInfluentialIGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
Christiansen, J., Kolte, A. M., Hansen, T. V. O., & Nielsen, F. C. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0016 · Cited by 182
Yaniv, K., & Yisraeli, J. K. (2002) · Gene · doi:10.1016/s0378-1119(01)00866-6 · Cited by 173
Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer
Hammer, N. A., Hansen, T. V. O., Byskov, A. G., Meyts, E. R.-D., Grøndahl, M. L., Bredkjær, H. E., Wewer, U. M., Christiansen, J., & Nielsen, F. C. (2005) · Reproduction · doi:10.1530/rep.1.00664 · Cited by 160
Human mitochondrial complex I assembly: A dynamic and versatile process
Vogel, R. O., Smeitink, J. A. M., & Nijtmans, L. G. J. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.07.008 · Cited by 151
Suissa, M., & Schatz, G. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33620-2 · Cited by 146
Sylvestre, J., Margeot, A., Jacq, C., Dujardin, G., & Corral‐Debrinski, M. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0074 · Cited by 142
Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma
Köbel, M., Weidensdorfer, D., Reinke, C., Lederer, M., Schmitt, W., Zeng, K., Thomssen, C., Hauptmann, S., & Hüttelmaier, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210563 · Cited by 136
Tumor Hypoxia and Gene Expression: Implications for Malignant Progression and Therapy
Sutherland, R. M. (1998) · Acta Oncologica · doi:10.1080/028418698430278 · Cited by 129
Murray, J. M., Zhang, B., Taylor, S. W., Oglesbee, D., Fahy, E., Marusich, M. F., Ghosh, S. S., & Capaldi, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300064200 · Cited by 121
Expression of oncofetal RNA‐binding protein CRD‐BP/IMP1 predicts clinical outcome in colon cancer
Dimitriadis, E., Trangas, T. T., Milatos, S., Foukas, P. G., Gioulbasanis, I., Courtis, N., Nielsen, F. C., Pandis, N., Dafni, U. G., Bardi, G., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22716 · Cited by 95
Role of the RNA-Binding Protein IMP-2 in Muscle Cell Motility
Boudoukha, S., Cuvellier, S., & Polesskaya, A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00665-10 · Cited by 65
Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process
Ezhilarasan, R., Mohanam, I., Govindarajan, K., & Mohanam, S. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.3.701 · Cited by 40
Görlach, A., & Acker, H. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90085-x · Cited by 34
Currle, D. S., & Gilbertson, R. J. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.08.011 · Cited by 10
Research works printed but not linked: 3
- 10.1006/abio.1997.2061 · doi:10.1006/abio.1997.2061
- 2005, Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma, Int J Oncol, 27, 1079
- 2005, Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma, Int J Oncol, 26, 311
Cited by
The role of m6A modification in the biological functions and diseases
Jiang, X., Liu, B., Nie, Z., Duan, L., Xiong, Q., Jin, Z., Yang, C., & Chen, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00450-x · Cited by 2,335
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Suvà, M. L., Rheinbay, E., Gillespie, S. M., Patel, A. P., Wakimoto, H., Rabkin, S. D., Riggi, N., Chi, A. S., Cahill, D. P., Nahed, B. V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.030 · Cited by 944
Self-citationWang, T., Fahrmann, J. F., Lee, H., Li, Y.-J., Tripathi, S. C., Yue, C., Zhang, C., Lifshitz, V., Song, J., Yuan, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.001 · Cited by 825
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Li, T., Hu, P.-S., Zuo, Z., Lin, J.-F., Li, X., Wu, Q.-N., Chen, Z.-H., Zeng, Z.-L., Wang, F., Zheng, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1038-7 · Cited by 799
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
Metadata
- Authors
- Janiszewska, M., Suvà, M. L., Riggi, N., Houtkooper, R. H., Auwerx, J., Clément-Schatlo, V., Radovanovic, I., Rheinbay, E., Provero, P., & Stamenkovic, I.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-08-16
- Volume
- 26
- Issue
- 17
- Pages
- 1926-1944
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2127307105
- Cited by
- 452
- References
- 62
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.